OTC:RVPH | Free Cash Flow | REVIVA PHARMACEUTICALS HOLDINGS, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-05-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$3.8M
2025-12-31-$5.8M
2025-03-31-$8.19M
2024-12-31-$9.1M
2024-03-31-$11.73M
2023-12-31-$8.88M
2023-03-31-$7.95M
2022-12-31-$4.69M
2022-03-31-$6.27M
2021-12-31-$3.9M
2021-03-31-$3.12M
2020-12-31-$2.94M
2020-05-31-$35,457.00
2020-03-31-$60,662.00
2020-02-29-$247,850.00
2019-05-31-$39,363.00
2019-02-28-$87,910.00
2018-05-31$11,659.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$24.59M
2024-12-31-$33.54M
2023-12-31-$28.32M
2022-12-31-$18.96M
2021-12-31-$10.67M
2020-12-31-$4.07M
2020-02-29-$426,591.00
2019-12-31-$218,444.00
2019-02-28-$220,869.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.